In focus
Latest feed
ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders
A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting
The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies
The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients
